Literature DB >> 23246048

Ischemic postconditioning protects the spinal cord from ischemia-reperfusion injury via modulation of redox signaling.

Wenying Song1, Jing Sun, Binxiao Su, Rui Yang, Hailong Dong, Lize Xiong.   

Abstract

BACKGROUND: It is well known that ischemic postconditioning reduces ischemic-reperfusion injury, but the underlying mechanism is not fully understood. The current study investigated the role of reactive oxygen species-mediated upregulation of endogenous antioxidant enzymes in the generation of a protective effect induced by ischemic postconditioning against spinal cord reperfusion injury in the rabbit.
METHODS: New Zealand White rabbits were randomly allocated to sham, ischemia-reperfusion, and postconditioning groups (3 cycles of 30 seconds of reperfusion and 30 seconds of occlusion during the onset of reperfusion). Spinal cord ischemia was induced by clamping the infrarenal abdominal aorta for 20 minutes in the ischemia-reperfusion and postconditioning groups. Forty-eight hours after reperfusion, the neurologic status of the lower limbs was assessed. Blood samples were collected for analysis of serum neuron-specific enolase levels, and the lumbar spinal cord segments (L5-7) were harvested for histopathologic and antioxidant enzyme activities and mRNA analysis with or without administration of N-2-mercaptopropionylglycine (an effective oxygen free radical scavenger) given at different reperfusion times.
RESULTS: Continuous administration of N-2-mercaptopropionylglycine for 13 minutes, starting at 10 minutes before (but not 10 minutes after) the beginning of reperfusion, attenuated the neuroprotective effect of postconditioning against spinal cord ischemia and reversed the increase in activity of the antioxidant enzymes superoxide dismutase and catalase in spinal cord tissue subjected to ischemic postconditioning.
CONCLUSIONS: The results indicate that reactive oxygen species-triggered upregulation of endogenous antioxidant enzyme activities may be involved in the mechanism of neuroprotection of ischemic postconditioning.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  38; 38.1; 38.2; GAPDH; I/R; IPC; MPG; N-2-mercaptopropionylglycine; NSE; PostC; ROS; SOD; glyceraldehyde 3-phosphate dehydrogenase; ischemia–reperfusion; ischemic preconditioning; neuron-specific enolase; postconditioning; reactive oxygen species; superoxide dismutase

Mesh:

Substances:

Year:  2012        PMID: 23246048     DOI: 10.1016/j.jtcvs.2012.11.039

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Evolving possible link between PI3K and NO pathways in neuroprotective mechanism of ischemic postconditioning in mice.

Authors:  Puja Gulati; Nirmal Singh
Journal:  Mol Cell Biochem       Date:  2014-08-24       Impact factor: 3.396

2.  Development of a modified model of spinal cord ischemia injury by selective ligation of lumbar arteries in rabbits.

Authors:  W Xiao; J Wen; Y-C Huang; B-S Yu
Journal:  Spinal Cord       Date:  2017-06-13       Impact factor: 2.772

3.  Lipoxin A4 ameliorates ischemia/reperfusion induced spinal cord injury in rabbit model.

Authors:  Zhi-Qiang Liu; Hong-Bin Zhang; Jian Wang; Li-Jian Xia; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Experimental Study on the Role of Apelin-13 in Alleviating Spinal Cord Ischemia Reperfusion Injury Through Suppressing Autophagy.

Authors:  Zhewei Xu; Zhiyue Li
Journal:  Drug Des Devel Ther       Date:  2020-04-22       Impact factor: 4.162

5.  Application of ischemic postconditioning's algorithms in tissues protection: response to methodological gaps in preclinical and clinical studies.

Authors:  Saeid Feyzizadeh; Reza Badalzadeh
Journal:  J Cell Mol Med       Date:  2017-04-12       Impact factor: 5.310

Review 6.  Neuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases.

Authors:  Jia Liu; Yakun Gu; Mengyuan Guo; Xunming Ji
Journal:  CNS Neurosci Ther       Date:  2021-08       Impact factor: 5.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.